Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Salvage Oligometastasectomy and Radiation Therapy in Recurrent Prostate Cancer (SOAR)

NCT03796767 is registered in ClinicalTrials.gov with University of Utah as lead sponsor.

NCT NCT03796767
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03796767 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Salvage Oligometastasectomy and Radiation Therapy in Recurrent Prostate Cancer (SOAR)
Lead sponsor
University of Utah
Phase
Phase 2
Overall status
Completed
Start date
September 9, 2019
Completion date
March 11, 2026
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic malignant neoplasm in the bone, metastatic malignant neoplasm in the lymph nodes, oligometastasis, prostate adenocarcinoma, psa failure, recurrent prostate carcinoma